Current position:Home >Product >
bis(4-[(2-chlorophenyl)[4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene]methyl]-N-ethyl-o-toluidine) sulphate
bis(4-[(2-chlorophenyl)[4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene]methyl]-N-ethyl-o-toluidine) sulphate(83950-19-0)
- Name: bis(4-[(2-chlorophenyl)[4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene]methyl]-N-ethyl-o-toluidine) sulphate
- Synonyms:EINECS 281-472-7;
- Molecular Formula:C50H56Cl2N4O4S
- Molecular Weight:879.97504
- CAS Registry Number:83950-19-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.83950-19-0 Bis(4-((2-chlorophenyl)(4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene)methyl)-N-ethyl-o-toluidine) sulphate
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.83950-19-0 Bis(4-((2-chlorophenyl)(4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene)methyl)-N-ethyl-o-toluidine) sulphate
Assay:99% Appearance:white powder Package:drum or based on customers' requirement Storage:normal temperature storage Transportation:by sea, by air Application:We have different specifications for different applications
Min. Order:1Metric Ton
Supplier:Bluecrystal chem-union [
China (Mainland)]
Other Product
- 150624-44-5/8,12,45,46,47,48,50-Heptaoxaheptacyclo[39.3.1.11,5.19,13.115,19.125,29.129,33]pentacont-23-ene-7,35-dione,3,37-bis(acetyloxy)-10,14,15,17,27,43-hexahydroxy-11-[(4S,5E)-4-hydroxy-2-methylene-5,7-octadien-1-yl]-31-methoxy-18,36,38,43,49-pentamethyl-39-methylene-,(1S,3S,5R,9R,10R,11R,13R,14S,15R,17S,18R,19R,23Z,25R,27S,29S,31S,33S,36S,37S,38R,41S,43S,49S)-
- 107604-86-4/1-naphthalen-1-yl-3-phenylimidazo[2,1-b]quinazolin-5(1H)-one
- 91666-91-0/3,4-Dimethylangelicin
- 63879-42-5/bis[2-(4-phenylpiperazin-1-yl)ethyl] 2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxylate
- 6322-91-4/4-benzyl-2,3-diphenylmorpholin-2-ol
- 167172-80-7/Sulfuric acid,mono[(2S,3aS,6R,7aS)-2-[[[4-[(aminoiminomethyl)amino]butyl]amino]carbonyl]-1-[(2R,3S)-2-[[(2R)-3-(3-chloro-4-hydroxyphenyl)-2-hydroxy-1-oxopropyl]amino]-3-methyl-1-oxopentyl]octahydro-1H-indol-6-yl]ester
- 81932-55-0/Furosinin (a form)
- 51324-49-3/4-methoxy-6-({2-[(Z)-(3-methoxy-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]hydrazino}methylidene)cyclohexa-2,4-dien-1-one
- 120365-34-6/Exogastrula-inducing peptide A, anthocidaris crassispina
- 34020-33-2/5-Guanylic acid, 6-S-methyl-6-thio-
- 86014-72-4/Cuprate(3-), (3-((2,4-dihydroxy-3-((2-hydroxy-5-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)phenyl)azo)-1,5-naphthalenedisulfonato(5-))-, sodium
- 85977-73-7/P-ITB
- 10212-28-9/Cyclo-C
- 2675-80-1/1-chloro-2,3,4-trimethoxy-benzene
- 90794-36-8/2-(4-iodophenoxy)butanoic acid
- 70680-01-2/[(2E)-3-phenylprop-2-en-1-ylidene]propanedioyl dichloride
- 94088-63-8/2'-(dibenzylamino)-6'-(dibutylamino)spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one
- 7225-66-3/7-Hexyltridecane.
- 207397-30-6/Pyropheoporphyrin c1
- 83950-19-0/bis(4-[(2-chlorophenyl)[4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene]methyl]-N-ethyl-o-toluidine) sulphate
- 4897-44-3/5-[(benzylsulfanyl)methyl]pyrimidine-2,4(1H,3H)-dione
- 37281-52-0/1-phenylethyl (2E)-3-[(dimethoxyphosphoryl)oxy]but-2-enoate - 2,2-dichloroethenyl dimethyl phosphate (1:1)
- 112503-95-4/b-D-Glucopyranoside,2-(3,4-dihydroxyphenyl)ethyl O-b-D-glucopyranosyl-(1®6)-O-[2,3,4-tri-O-acetyl-6-deoxy-a-L-mannopyranosyl-(1®3)]-, 2-acetate 4-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate](9CI)
- 6324-74-9/N-[4-(5,6-dimethyl-1,3-benzoxazol-2-yl)phenyl]-5-(2-nitrophenyl)furan-2-carboxamide
- 13522-36-6/O-(4-nitrophenyl) methyl(4-nitrophenyl)carbamothioate
- 194851-33-7/Naphtho[2,3-c]furan-1(3H)-one,4-[(6-O-â- D-glucopyranosyl-â-D-glucopyranosyl)oxy]-5- methoxy-3-methyl-,(3R)-
- 42204-38-6/8-(hydroxymethyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione
- 88509-91-5/dichotomitin
- 6303-92-0/6-(4,5-dihydro-1,3-thiazol-2-yl)-5H-purine
- 24237-39-6/ETHYL 2-AMINO-6-METHYL-4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDINE-3-CARBOXYLATE